Navigation Links
Fingertip Formulary Restrictions(TM) Provides Unprecedented Access to Real- Time Managed Care Restrictions Data
Date:9/25/2007

GLEN ROCK, N.J., Sept. 25 /PRNewswire/ -- Fingertip Formulary announces the availability of Fingertip Formulary Restrictions, a cutting edge, internet-based platform that provides access to detailed managed care prescription rules and restrictions. Real-time custom reports, generated by Fingertip Formulary Restrictions, provide insight into relative pharmaceutical product access advantages and disadvantages, barriers to prescribing, as well as overall performance from a prescription claims standpoint. Results are immediately available online and may be downloaded for further analysis.

Leveraging its existing online database, Fingertip Formulary Analytics(R), Fingertip Formulary Restrictions offers access to detailed clinical criteria and rules required for prior authorization, step therapy, quantity limits, and other similar restrictions. Data may be reviewed on a national, regional, or state basis, as well as by health plan type. By segmenting the market and by gaining understanding into these differences, subscribers create opportunities to develop and enhance professional education and marketing programs.

"Our customers have frequently requested detailed intelligence on prescription restrictions. Now Fingertip Formulary offers the most comprehensive data in the industry - in the only way we know how - real-time, available anywhere, over the internet," said Mike Green, Vice President of Sales and Business Development.

About Fingertip Formulary(R)

Fingertip Formulary (http://www.FingertipFormulary.com) offers comprehensive formulary data covering commercial, Medicaid, Medicare, and PBM plans, among others, in the United States. Fingertip Formulary offers a variety of unique data and marketing solutions for the pharmaceutical industry, consultants, and healthcare providers that provide access to and insight into formulary data. Fingertip Formulary also provides formulary dat
'/>"/>

SOURCE Fingertip Formulary
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. MedAir AB Announces the Launch of Fingertip Pulse Oximeter
2. Protein provides antioxidant protection to Neurons
3. Acupuncture provides relief
4. Micro-camera provides new breast imaging technique
5. Hormone therapy provides no heart benefit
6. MicroRNA provides new insight into birth defects
7. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
8. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
9. Cholesterol provides immunity against infection by certain parasites
10. John Hopkins CGHH program provides Global Health education
11. London Hospital Provides Specialized Care For Pregnant Women

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... , SEATTLE, Nov. 27 A...ed record-high Thanksgiving traffic numbers, with ...ksgiving, providing a clear picture of what was se...average Thanksgiving meal in 2009 weighed in at 2,...m last year,s feast. According to the Allrecipes s...
(Date:11/27/2009)... Specialist manufacturers who use medi...saving millions of dollars by bringing in technolo...creasing numbers of pro-active medical manufacture... concept stage of their projects, ensuring that pr...processes or potentially outdated technology. , ...
(Date:11/26/2009)... PRINCETON, N.J., Nov. 27 The diab...ouble over the next 25 years and annual medical sp...lion, up from $113 billion today, according to a s...Care . The National Changing Diabetes ® Pro...ed the analysis by a team from the University of C...
(Date:11/26/2009)...s too big or too heavy can lead to strains or wors... -- There may be nothing wrong with stuffing your ... do the same thing with your suitcase as you pack ...re treated in 2008 in U.S. hospital emergency room...ilities for luggage-related injuries, such as musc...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again ...n Dallas , is one of a growing number of physician...orking sites to connect with individuals who are i...ht morbid obesity. Dr. Kim is utilizing Facebook t...out his practice with the community. , ...
Breaking Medicine News(10 mins):Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3
...etwork, Inc. (http://www.HealthCentral.com ) has ...edical and peer-to-peer resource,committed to help...out,drugs, surgeries and nutrition, along with off...th reporter Amy Hendel, and trainer and,motivation...
...or, Judy Bachrach Launches Newly, Redesigned Advic...nd Those Who Are Close to ...ttp://www.thecheckoutline.org - the first-ever on...eaders to discuss,their own issues. Launched by aw...
... , People who have had a stroke and the people w... manage the consequences of stroke. As well as the...s difficult to cope with. It is not only stroke pa...QWiG) has now assessed research on treatments for ...
...em,will be the focus of an international conferenc...sland nation,s healthcare system could be transfor...n to follow. Affiliated,Computer Services, Inc. (A...xperts in healthcare and information technology wi...
...t would cut $358 million,from the Medicare Advanta...across Texas are,speaking out against proposed cut... being considered in the U.S. Senate. The legislat...or-service plans can operate, adversely impacting ...
...th an epidemic that has outpaced nearly all effort...gies centered on the same antiretroviral (ARV) dru...n hopes they will be as effective a stronghold for...omise because it can be formulated as either an or...
Other Medicine News:Health News:Responding to Increased Incidence of Obesity and Associated Health Issues, The HealthCentral Network Launches Site to Support those Struggling with Weight 2Health News:Online Advice Column Receives Critical Acclaim; Baby Boomers Found Resourceful During Crisis 2Health News:Depression after stroke: A neglected problem 2Health News:Depression after stroke: A neglected problem 3Health News:ACS Forum to Showcase Innovative Healthcare Model for European Union 2Health News:ACS Forum to Showcase Innovative Healthcare Model for European Union 3Health News:Texas Seniors Speak Out Against Medicare Advantage Cuts 2Health News:HIV prevention researchers to compare common ARV as a pill and vaginal gel in unique study 2Health News:HIV prevention researchers to compare common ARV as a pill and vaginal gel in unique study 3Health News:HIV prevention researchers to compare common ARV as a pill and vaginal gel in unique study 4
(Date:11/25/2009)..., , RANCHO CORDOVA, Calif., Nov. 25 /PRNews...ary of American Pacific Corporation (Nasdaq: APFC...tal Responsibility and Sustainability Award at the...by the California Manufacturers and Technology Ass...ciation (IEA) and the Chemical Industry Council of...
(Date:11/25/2009)..., , HARBIN, China, Nov. 25 /PRNews.... ("China Sky One Medical" or "the Company") (Nasd...ical company developing and producing,over-the-cou..."), today,announced that the Company recently pass...of Pharmaceutical and Biological Products ("ICPBP"...
(Date:11/25/2009)..., , NEW YORK, Nov. 25 ...arch report is available in its catalogue: ,, ...ve ,, http://www.reportlinker.com/p0164330/M....html ,, Rising incidence of breast cancer in ...principal factor influencing growth in the mammogr...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA 2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4586 1VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA 2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4586 2VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA 2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4586 3VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA 2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4586 4VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA 2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4586 5nCircle and HITRUST Partner to Deliver Innovative SaaS Offering to Secure Healthcare Information 48586 1nCircle and HITRUST Partner to Deliver Innovative SaaS Offering to Secure Healthcare Information 48586 2nCircle and HITRUST Partner to Deliver Innovative SaaS Offering to Secure Healthcare Information 48586 3nCircle and HITRUST Partner to Deliver Innovative SaaS Offering to Secure Healthcare Information 48586 4ReStart DC Launches Life Saving Public Access Defibrillation Program 48583 1ReStart DC Launches Life Saving Public Access Defibrillation Program 48583 2ReStart DC Launches Life Saving Public Access Defibrillation Program 48583 3
...(BUSINESS WIRE)--Jun 25, 2007 - Neurogen,Corporati...e,results from two dose-ranging, Phase 2b clinical...any,s proprietary insomnia agent,NG2-73, an alpha...rmulations were studied in each trial to determine...maintenance of sleep,through the night without res...
...f.--(BUSINESS WIRE)--Jun 25, 2007 - Gilead,Science...03, a,Phase III clinical trial evaluating the comp...r disoproxil fumarate or tenofovir,DF) 300 mg as a...,(HBV) infection, met its primary efficacy endpoin...e company,s once-daily antiviral,drug Hepsera(R) (...
Other Medicine Technology:Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 2Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 3Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 4Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 5Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 6Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 7Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 8Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 2Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 3Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 4Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 5Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 6
Reference Lab Interface (RLI)©
PM-9000 Express Patient Monitor
...M-labeled probe that is designed to detect Flu A a...addition, this ASR contains primers and a Texas Re...ntrol. This ASR requires an instrument that can de...ch as the Cepheid SmartCycler System. The Cepheid ...
...beled probe that is designed to detect Respiratory...ains primers and a Texas Red-labeled probe for a,...ires an instrument that can detect FAM and Texas R...ystem. The Cepheid Analyte Specific Reagent* (ASR)...
Medicine Products: